Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ImmunoGen's Symbiotic Relationships Thru TAP Will Beef Up Its Stock Price
Seeking Alpha
Friday, May 10, 2013 - 8:40am
tags:
Immunogen, Targeted Antibody Payload
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived
Seeking Alpha
Friday, May 10, 2013 - 8:31am
tags:
Cellceutix, AstraZeneca, GSK, Celgene, Eli Lilly, Roche, Pfizer, Pharmacyclics, Kevetrin, cancer
Horizon Pharma Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Friday, May 10, 2013 - 8:29am
tags:
Horizon Pharma, earnings
Johnson & Johnson deal to settle sales practices probe stalls
The Fly on the Wall
Friday, May 10, 2013 - 8:28am
tags:
JNJ
Review Of Depomed First Quarter 2013 Results
Seeking Alpha
Thursday, May 9, 2013 - 12:00pm
tags:
Depomed, earnings
Merck's Liptruzet: A Cause For Shame?
Seeking Alpha
Thursday, May 9, 2013 - 11:59am
tags:
Merck, Liptruzet
Sarepta's Meaningless Q1 Results
Motley Fool
Thursday, May 9, 2013 - 11:58am
tags:
earnings, Sarepta
Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says
Fierce Pharma
Thursday, May 9, 2013 - 9:48am
tags:
Novo Nordisk, Victoza, Tresiba, diabetes
DENTSPLY Misses Earnings Est; Outlook Down
Yahoo/Zacks
Thursday, May 9, 2013 - 9:47am
tags:
Dentsply, earnings, dental, devices
Takeda forecasts 28% slide in profit on weak sales
Marketwatch
Thursday, May 9, 2013 - 9:43am
tags:
earnings, Takeda
Nanostim’s Mini Wireless Pacemaker Shows Promise in Study
Bloomberg
Thursday, May 9, 2013 - 9:42am
tags:
pacemakers, wireless pacemakers, Nanostim, St. Jude Medical, devices
Gilead's Hepatitis C Drug Sofosbuvir Offers Upside
Seeking Alpha
Thursday, May 9, 2013 - 9:40am
tags:
hepatitis C, sofosbuvir, Gilead
Biotech Is Where the Bucks Are
Yahoo/TheStreet.com
Thursday, May 9, 2013 - 9:39am
tags:
biotech
Obesity Drug Demand Still Low
Motley Fool
Thursday, May 9, 2013 - 9:32am
tags:
obesity, Vivus, Arena Pharmaceuticals, Qsymia, Belviq, Eisai
Sanford Heisler Files $100m+ Gender Discrimination Suit Against Merck
Yahoo
Thursday, May 9, 2013 - 9:24am
tags:
gender discrimination, Merck, drug reps
Independent Study Showed Decrease in Operating Room Visits for Patients with Infected Wounds using Adjunctive V.A.C. VeraFlo™ Therapy
CP Wire
Thursday, May 9, 2013 - 9:16am
tags:
devices, Kinetic Concepts, V.A.C. VeraFlo™ Therapy, wound care
Takeda buys US vaccines maker Inviragen
Pharma Times, UK
Thursday, May 9, 2013 - 9:06am
tags:
Teva, Inviragen, M&A, vaccines
Amarin Trouble Grows As Does Evidence Against Fish Oil's Benefits
TheStreet.com
Thursday, May 9, 2013 - 8:51am
tags:
Amarin, Vascepa, fish oil
Johnson & Johnson: Banking On Industry Revival
Seeking Alpha
Thursday, May 9, 2013 - 8:48am
tags:
JNJ
Medivation Earnings: Your Sneak Peek to the Big Announcement
Wall St. Cheat Sheet
Thursday, May 9, 2013 - 8:40am
tags:
devices, Medivation, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.